Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen

See Locations Near You

Summary

This study will compare PF-00299804 given orally on continuous schedule to the approved drug, erlotinib, in patients whose non-small cell lung cancer has progressed after chemotherapy; patients will be randomized to receive one of these drugs, and followed for efficacy and tolerance of each.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

advanced measurable Non-Small Cell Lung Cancer (NSCLC);
progressed after 1-2 prior chemotherapy;
Eastern Cooperative Oncology Group (ECOG) 0-2;
tissue available for future KRAS/ EGFR testing

Exclusion Criteria:

prior Epidermal Growth Factor Receptor (EGFR) targeted therapy;
active or untreated Central Nervous System (CNS) metastases;

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

188

Study ID:

NCT00769067

Recruitment Status:

Completed

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 53 Locations for this study

See Locations Near You

Northwest Alabama Cancer Center
Muscle Shoals Alabama, 35661, United States
Agajanian Institute of Oncology and Hematology
Montebello California, 90640, United States
Bridgeport Hospital
Bridgeport Connecticut, 06610, United States
Wittingham Cancer Center @ Norwalk Hospital
Norwalk Connecticut, 06856, United States
Medical Oncology & Hematology, P.C.
Waterbury Connecticut, 06708, United States
Winship Cancer Institute at Grady Health Systems
Atlanta Georgia, 30303, United States
Winship Cancer Institute, Emory University
Atlanta Georgia, 30322, United States
Winship Cancer Institute at Emory University
Atlanta Georgia, 30322, United States
Winship Cancer Institute of Emory University
Atlanta Georgia, 30322, United States
Winship Cancer Institute, Emory University
Atlanta Georgia, 30322, United States
Augusta Oncology Associates, P.C.
Augusta Georgia, 30901, United States
Augusta Oncology Associates, PC
Augusta Georgia, 30909, United States
John B. Amos Cancer Center
Columbus Georgia, 31904, United States
Georgia Cancer Specialists
Decatur Georgia, 30033, United States
The Longstreet Cancer Center
Gainesville Georgia, 30501, United States
Central Georgia Cancer Care, P.C.
Macon Georgia, 31201, United States
Northwest Georgia Oncology Center
Marietta Georgia, 30106, United States
Central Georgia Cancer Care, P.C.
Warner Robins Georgia, 31088, United States
Kootenai Cancer Center at Post Falls
Post Falls Idaho, 83854, United States
Kootenai Cancer Center
Post Falls Idaho, 83854, United States
Midwestern Regional Medical Center
Zion Illinois, 60099, United States
Center for Blood and Cancer Disorders
Bethesda Maryland, 20817, United States
Associates in Oncology/Hematology, PC
Rockville Maryland, 20850, United States
University of Minnesota Cancer Center
Minneapolis Minnesota, 55455, United States
The West Clinic
Memphis Tennessee, 38120, United States
Oncology/Hematology Associates
Clarksburg West Virginia, 26301, United States
Chris O'Brien Lifehouse
Camperdown New South Wales, 2050, Australia
St. Vincent's Hospital
Fitzroy Victoria, 3065, Australia
The Andrew Love Cancer Centre,
Geelong Victoria, 3220, Australia
Border Medical Oncology
Wodonga Victoria, 3690, Australia
Irmandade da Santa Casa de Misericordia de Porto Alegre (ISCMPA) - Hospital Santa Rita
Porto Alegre RS, 90050, Brazil
Hospital Sao Lucas da PUCRS
Porto Alegre RS, 90610, Brazil
FUNDACAO PIO XII Hospital de Cancer de Barretos
Barretos SP, 14784, Brazil
Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira - ICESP
Sao Paulo SP, 01246, Brazil
BC Cancer Agency - Vancouver Centre
Vancouver British Columbia, V5Z 4, Canada
Royal Victoria Hospital
Barrie Ontario, L4M 6, Canada
RSM Durham Regional Cancer Centre - Lakeridge Health Oshawa
Oshawa Ontario, L1G 2, Canada
The Ottawa Hospital Cancer Centre
Ottawa Ontario, K1H 8, Canada
Department of Clinical Oncology
Shatin New Territories, , Hong Kong
Department of Clinical Oncology, Tuen Mun Hospital
Tuen Mun New Territories, , Hong Kong
Seoul National University Hospital
Seoul , 110-7, Korea, Republic of
Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center
Seoul , 120-7, Korea, Republic of
SamsungMedicalCenter,SungkyunkwanUnivSchoolofMedicine,Div. of Hematology-Oncology, Dep. of Medicine
Seoul , 135-7, Korea, Republic of
Medex spolka cywilna
Chrzanow , 32-50, Poland
¿KardioDent¿
Krakow , 30-04, Poland
"Vesalius" Sp. z o.o.
Krakow , 31-10, Poland
Zaklad Rentgena i USG Wyrobek spolka jawna
Krakow , 31-21, Poland
Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie
Warsaw , 02-78, Poland
Niepubliczny Zaklad Opieki Zdrowotnej AVI Centrum Medyczne
Warszawa , 00-72, Poland
Ponce School of Medicine / CAIMED Center
Ponce , 00716, Puerto Rico
National Cancer Centre
Singapore , 16961, Singapore
Hospital Universitari Germans Trias I Pujol
Badalona Barcelona, 08916, Spain
Hospital Son Llatzer
Palma de Mallorca Islas Baleares, 07198, Spain
Hospital de Cruces
Barakaldo Vizcaya, 48903, Spain
Hospital Teresa Herrera
La Coruña , 15006, Spain
National Taiwan University Hospital
Taipei , 100, Taiwan
Taipei Veterans General Hospital, Chest Department
Taipei , 112, Taiwan
Christie Hospital NHS Foundation Trust
Manchester , M20 4, United Kingdom
Churchill Hospital
Oxford , OX3 7, United Kingdom
Load More

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

188

Study ID:

NCT00769067

Recruitment Status:

Completed

Sponsor:


Pfizer

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider